Growing community of inventors

San Diego, CA, United States of America

Nicole Smith

Average Co-Inventor Count = 13.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 36

Nicole SmithMartin W Rowbottom (7 patents)Nicole SmithWarren Stanfield Wade (7 patents)Nicole SmithMi Chen (7 patents)Nicole SmithTimothy Richard Coon (7 patents)Nicole SmithNeil Ashweek (7 patents)Nicole SmithTodd Ewing (7 patents)Nicole SmithYun-Fei Zhu (7 patents)Nicole SmithRichard B Lowe (7 patents)Nicole SmithGraham Beaton (7 patents)Nicole SmithWanlong Jiang (7 patents)Nicole SmithWilly Moree (7 patents)Nicole SmithLiren Zhao (7 patents)Nicole SmithNicole Smith (7 patents)Martin W RowbottomMartin W Rowbottom (41 patents)Warren Stanfield WadeWarren Stanfield Wade (32 patents)Mi ChenMi Chen (28 patents)Timothy Richard CoonTimothy Richard Coon (26 patents)Neil AshweekNeil Ashweek (24 patents)Todd EwingTodd Ewing (23 patents)Yun-Fei ZhuYun-Fei Zhu (18 patents)Richard B LoweRichard B Lowe (17 patents)Graham BeatonGraham Beaton (11 patents)Wanlong JiangWanlong Jiang (10 patents)Willy MoreeWilly Moree (9 patents)Liren ZhaoLiren Zhao (9 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Neurocrine Biosciences, Inc. (7 from 120 patents)


7 patents:

1. 11713324 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

2. 10941159 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

3. 10336769 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

4. 9422310 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

5. 8952161 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

6. 8481738 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

7. 8084614 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/14/2026
Loading…